◆ NeutralCAMP

CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire Inc.·
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMP4 Therapeutics granted non-qualified stock options to purchase 39,000 shares to three newly hired employees as inducement for employment. The options have a 10-year term, an exercise price of $3.96 per share, and will vest over four years with 25% vesting after one year followed by monthly installments.

Read Full Article at GlobeNewswire Inc.
← Back to Financial Intelligence